Unicycive Therapeutics

Los Altos, United States

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

Mar 2024

Post-IPO Equity

Biotechnology Health Care Health Diagnostics Medical

Top Investors

RA Capital ManagementVivo CapitalGreat Point PartnersWalleye CapitalOctagon Capital Advisors

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Unicycive Therapeutics

Who are Unicycive Therapeutics's investors?

Unicycive Therapeutics's investors include RA Capital Management, Vivo Capital, Great Point Partners, Walleye Capital, Octagon Capital Advisors.

Where is Unicycive Therapeutics headquartered?

Unicycive Therapeutics is headquartered in Los Altos, United States.

What does Unicycive Therapeutics do?

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

What stage is Unicycive Therapeutics at?

Unicycive Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 14, 2024.

MLA

"Unicycive Therapeutics — Funding & Investors." VCBacked, March 14, 2024, https://www.vcbacked.co/company/unicycive-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Unicycive Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/unicycive-therapeutics

Wikipedia (cite web)

{{cite web |title=Unicycive Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/unicycive-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 14, 2024.